| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Taiwan | 6 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | China | 4 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Republic of Korea | 2 | |
| #6 | Australia | 1 | |
| #7 | Canada | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Gu Ming | 22 |
| #2 | Samuelsson Bengt Ingemar | 20 |
| #3 | Janson Jan-Christer | 5 |
| #4 | Samuelsson Bengt I | 4 |
| #5 | Meng Nan | 2 |
| #6 | Song Maoqian | 1 |
| #7 | Janson Jan Christer | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021047648A1 | New peptides | |
| TW202042813A | New formulations containing leukotriene receptor antagonists | |
| CN111601618A | Novel conjugates of montelukast and peptides | |
| WO2019228307A1 | New pharmaceutical use | |
| WO2019011286A1 | Antiviral use of mussel adhesive proteins | |
| CN110312513A | Combined topical formulations comprising montelukast Yu mussel attachment proteins | |
| CN110139662A | The antiphlogistic use of peptide |